Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.

about

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q54263200

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Eplerenone attenuates patholog ...... lmonary arterial hypertension.

@en

Eplerenone attenuates patholog ...... lmonary arterial hypertension.

@nl

type

Item

label

Eplerenone attenuates patholog ...... lmonary arterial hypertension.

@en

Eplerenone attenuates patholog ...... lmonary arterial hypertension.

@nl

prefLabel

Eplerenone attenuates patholog ...... lmonary arterial hypertension.

@en

Eplerenone attenuates patholog ...... lmonary arterial hypertension.

@nl

P1476

Eplerenone attenuates patholog ...... lmonary arterial hypertension.

@en

P2093

Allan Lawrie

http://www.w3.org/2001/XMLSchema#string

Changwu Lu

http://www.w3.org/2001/XMLSchema#string

David G Kiely

http://www.w3.org/2001/XMLSchema#string

Friedrich Grimminger

http://www.w3.org/2001/XMLSchema#string

Josephine Pickworth

http://www.w3.org/2001/XMLSchema#string

Mario Boehm

http://www.w3.org/2001/XMLSchema#string

Nadine Arnold

http://www.w3.org/2001/XMLSchema#string

Norbert Weissmann

http://www.w3.org/2001/XMLSchema#string

Ralph T Schermuly

http://www.w3.org/2001/XMLSchema#string

Tatyana Novoyatleva

http://www.w3.org/2001/XMLSchema#string

P2860

5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure

Eplerenone (Inspra), a new aldosterone antagonist for the treatment of systemic hypertension and heart failure

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension

Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner.

Inducible Knock-Down of the Mineralocorticoid Receptor in Mice Disturbs Regulation of the Renin-Angiotensin-Aldosterone System and Attenuates Heart Failure Induced by Pressure Overload.

Aldosterone and end-organ damage.

P2888

s12890-018-0604-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12890-018-0604-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101304944

http://www.w3.org/2001/XMLSchema#string

P698

29499691

http://www.w3.org/2001/XMLSchema#string

P932

5833097

http://www.w3.org/2001/XMLSchema#string